Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Plandai Biotechnology

Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
From Plandai Biotechnology
Via AccessWire
Tickers PLPL
SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
From Plandai Biotechnology
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers PLPL
Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market
From Plandai Biotechnology
Via AccessWire
Tickers PLPL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.